Teleflex (TFX) Gains from Investment Securities (2017 - 2026)
Teleflex's (TFX) quarterly Gains from Investment Securities came in at -$2.6 million in Q1 2026, down 46.63% YoY from -$4.9 million in Q1 2025, and down 809.43% on a QoQ basis from $371000.0 in Q4 2025.
Teleflex (TFX) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Teleflex (TFX) has 10 years of Gains from Investment Securities data on file, last reported at -$2.6 million in Q1 2026.
- Quarterly Gains from Investment Securities fell 46.63% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.6 million (up 111.88% YoY) and the FY2025 annual result came in at $16.4 million, up 64.02% from the prior year.
- Gains from Investment Securities eased to -$2.6 million in Q1 2026, from $371000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $15.9 million in Q2 2025 to a low of -$17.7 million in Q4 2023.
- A 5-year average of -$61882.4 and a median of $371000.0 in 2025 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 8256.67% in 2023, down 19345.65% in 2023.
- Tracing TFX's Gains from Investment Securities over 5 years: stood at $2.1 million in 2022, then sank by 230.67% to -$2.8 million in 2023, then surged by 193.48% to $2.6 million in 2024, then tumbled by 85.63% to $371000.0 in 2025, then tumbled by 809.43% to -$2.6 million in 2026.
- The last three Gains from Investment Securities figures came in at -$2.6 million (Q1 2026), $371000.0 (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Teleflex | 6.03 Bn | 5.73 Bn | 331.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -67,000.00 |
| Jun 30, 2026 | -67,000.00 |
| Mar 31, 2026 | -2.63 Mn |
| Mar 31, 2026 | -2.63 Mn |
| Dec 31, 2025 | 371,000.00 |
| Dec 31, 2025 | 371,000.00 |
| Sep 28, 2025 | 2.00 Mn |
| Sep 28, 2025 | 2.00 Mn |
| Jun 29, 2025 | 15.88 Mn |
| Jun 29, 2025 | 15.88 Mn |
| Mar 30, 2025 | -1.80 Mn |
| Mar 30, 2025 | -1.80 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 29, 2024 | 1.59 Mn |
| Sep 29, 2024 | 1.59 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Mar 31, 2024 | 865,000.00 |
| Mar 31, 2024 | 865,000.00 |